[{"address1": "5405 Windward Parkway", "address2": "Suite 100 South", "city": "Alpharetta", "state": "GA", "zip": "30004", "country": "United States", "phone": "844 428 2667", "website": "https://avanos.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.", "fullTimeEmployees": 3771, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joseph F. Woody", "age": 57, "title": "CEO & Director", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 2213877, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael C. Greiner", "age": 50, "title": "Senior VP, CFO & Chief Transformation Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 986416, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mojirade  James", "age": 56, "title": "Senior VP, General Counsel & Corporate Secretary", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 728665, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kerr W. Holbrook", "age": 56, "title": "Senior VP & Chief Commercial Officer", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 747614, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Joseph Hurley", "title": "Principal Accounting Officer & Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Crawford", "title": "VP of FP&A and Investor Relations and Treasurer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michelle  Scharfenberg", "title": "Senior VP and Chief Ethics & Compliance Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Galovan", "title": "Vice President of Strategy & Corporate Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "John W. Cato", "title": "Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lee  Burnes", "title": "Senior Vice President of Global R&D, Clinical and Medical Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 1, "compensationRisk": 2, "shareHolderRightsRisk": 7, "overallRisk": 3, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 23.91, "open": 24.07, "dayLow": 23.9, "dayHigh": 24.28, "regularMarketPreviousClose": 23.91, "regularMarketOpen": 24.07, "regularMarketDayLow": 23.9, "regularMarketDayHigh": 24.28, "beta": 0.908, "trailingPE": 160.86665, "forwardPE": 13.258241, "volume": 170244, "regularMarketVolume": 170244, "averageVolume": 220441, "averageVolume10days": 200390, "averageDailyVolume10Day": 200390, "bid": 24.11, "ask": 24.13, "bidSize": 1000, "askSize": 1000, "marketCap": 1108749312, "fiftyTwoWeekLow": 17.235, "fiftyTwoWeekHigh": 24.77, "priceToSalesTrailing12Months": 1.6247792, "fiftyDayAverage": 22.2046, "twoHundredDayAverage": 20.45335, "currency": "USD", "enterpriseValue": 1223569024, "profitMargins": 0.01128, "floatShares": 41802507, "sharesOutstanding": 45949000, "sharesShort": 730899, "sharesShortPriorMonth": 751545, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0159, "heldPercentInsiders": 0.02854, "heldPercentInstitutions": 0.94575995, "shortRatio": 3.28, "shortPercentOfFloat": 0.0227, "impliedSharesOutstanding": 45949000, "bookValue": 26.623, "priceToBook": 0.90635914, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": 7000000, "trailingEps": 0.15, "forwardEps": 1.82, "pegRatio": 2.76, "enterpriseToRevenue": 1.793, "enterpriseToEbitda": 10.317, "52WeekChange": 0.1830777, "SandP52WeekChange": 0.24014747, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "AVNS", "underlyingSymbol": "AVNS", "shortName": "Avanos Medical, Inc.", "longName": "Avanos Medical, Inc.", "firstTradeDateEpochUtc": 1413898200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "072d122b-2f4d-30a8-8d4c-00fcd10638d6", "messageBoardId": "finmb_251719973", "gmtOffSetMilliseconds": -14400000, "currentPrice": 24.13, "targetHighPrice": 27.0, "targetLowPrice": 24.0, "targetMeanPrice": 25.5, "targetMedianPrice": 25.5, "recommendationMean": 2.7, "recommendationKey": "hold", "numberOfAnalystOpinions": 2, "totalCash": 92200000, "totalCashPerShare": 2.009, "ebitda": 118600000, "totalDebt": 218300000, "quickRatio": 1.034, "currentRatio": 2.277, "totalRevenue": 682400000, "debtToEquity": 17.864, "revenuePerShare": 14.739, "returnOnAssets": 0.0276, "returnOnEquity": 0.0057, "freeCashflow": 163700000, "operatingCashflow": 61600000, "revenueGrowth": 0.014, "grossMargins": 0.55818003, "ebitdaMargins": 0.17379999, "operatingMargins": 0.06814, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]